|
Location: London
... need treatment, to pharmaceutical organizations losing billions through failed trials. Inoviv is changing the drug development landscape with our novel proteomic ... companies to develop biomarker discovery experiments and targeted assays utilizing Inoviv's rapid assay development modality, InoKey. You will be a ...
Company: Inoviv
(1 week ago)
|